Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece

Personalized Medicine
Yuan MaiGeorge P Patrinos

Abstract

In the postgenomic era, in many European countries, very little is known regarding the level of awareness of healthcare professionals with respect to pharmacogenomics and personalized medicine. Here, we report the findings of an in-depth study, involving 86 pharmacists and 208 physicians, to assess their level of awareness of pharmacogenomics and personalized medicine. Our findings indicate that approximately 60% of pharmacists consider their level of knowledge of personalized medicine to be very low, while over half of the pharmacists and physicians intimate that they would be unable to explain the results of pharmacogenomic tests to their customers or patients, respectively. This situation may be directly related to the low level of their undergraduate education in genetics and pharmacogenomics. These findings provide the basis for assessing the views of healthcare professionals in relation to personalized medicine in Greece, and should help to facilitate the integration of genomics into the medical decision-making process.

References

Dec 9, 2004·Pharmacogenomics·Kathryn A Phillips, Stephanie L Van Bebber
Apr 14, 2009·Genomic Medicine·Jenny E HiggsWilliam Newman
Oct 9, 2009·Genetic Testing and Molecular Biomarkers·Friedrich BalckWolfgang Meyer
Nov 26, 2009·Translational Research : the Journal of Laboratory and Clinical Medicine·Geoffrey S Ginsburg, Huntington F Willard
Dec 10, 2009·Nature Reviews. Genetics·Michael L Metzker
Jan 13, 2010·Nature Reviews. Genetics·Alan E GuttmacherKári Stefánsson
Jun 24, 2010·Clinical Genetics·J M ChenD N Cooper
Jun 10, 2011·American Journal of Pharmaceutical Education·Kristen B McCulloughWayne T Nicholson
Sep 15, 2011·Nature Reviews. Genetics·Larry J KrickaGeorge P Patrinos
Oct 18, 2011·Journal of the American Pharmacists Association : JAPhA·Susan M Reiss, UNKNOWN American Pharmacists Association
Oct 20, 2011·Pharmacogenomics·Heidi Carmen Howard, Pascal Borry
Jan 27, 2012·Clinical Pharmacology and Therapeutics·E J StanekF W Frueh
Oct 1, 2008·Public Opinion Quarterly·Eleanor SingerToni C Antonucci
Jan 1, 2013·American Journal of Pharmaceutical Education·Kelly C LeeGrace M Kuo
Jan 19, 2013·Pharmacogenomics·Simon de DenusBarbara Vadnais
Jul 10, 2013·Human Genomics·George P PatrinosDavid N Cooper
May 1, 2010·Personalized Medicine·Oksana A MakeevaValery P Puzyrev
Jul 1, 2011·Personalized Medicine·Aggeliki SagiaGeorge P Patrinos

❮ Previous
Next ❯

Citations

Jun 14, 2019·Personalized Medicine·Jeanette McCarthy, George P Patrinos
Oct 30, 2016·Pharmacogenomics·George P Patrinos, Theodora Katsila
Sep 1, 2016·European Journal of Human Genetics : EJHG·Cathelijne H van der WoudenHenk-Jan Guchelaar
Mar 1, 2017·Personalized Medicine·Lei-Shih ChenShixi Zhao
Sep 1, 2014·Personalized Medicine·David N CooperGeorge P Patrinos
Jun 30, 2019·Pharmacogenomics·Nataša Karas KuželičkiUNKNOWN European Society of Pharmacogenomics and Personalized Therapy (ESPT)
Sep 28, 2016·Public Health Genomics·Athanassios VozikisGeorge P Patrinos
Jun 18, 2015·Human Genomics·Konstantinos MitropoulosGeorge P Patrinos
Oct 3, 2020·American Journal of Human Genetics·George P PatrinosChristina Mitropoulou
Oct 2, 2021·BMC Health Services Research·Lina Albitar, Ghalia Abou Alchamat
Oct 3, 2021·Human Genetics·Evangelia Eirini TsermpiniGeorge P Patrinos
Oct 15, 2021·Omics : a Journal of Integrative Biology·George P Patrinos, Christina Mitropoulou

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

Statistical Package for the Social Sciences
Medco

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.